Market Report

Pharma Wholesale and Distribution Market Report 2025-2035

The global Pharma Wholesale and Distribution market is projected to grow at a CAGR of 7.8% by 2035

SKU: PHA1377 Category: Code: PHA1377Pages: 303
Clear
← Back to category Contract Services

Description

The Pharma Wholesale and Distribution Market Report 2025-2035 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Cold Chain Positions Itself as the Core of Specialty Pharma Growth

The pharmaceutical wholesale and distribution landscape is undergoing a decisive structural shift: cold chain is no longer a supportive logistics layer—it has become the industry’s core strategic backbone. With an expanding share of global pipelines centred on temperature-sensitive products—including vaccines, biologics, cell- and gene-based therapies, and the accelerating GLP-1 class—wholesalers and distributors are realigning their strategies according to the growing demand for frozen and refrigerated storage, validated packaging systems, and continuous temperature-integrity monitoring at scale.

This shift is reflected in two major 2025 announcements signalling a new phase of infrastructure modernisation. In March 2025, DHL confirmed its agreement to acquire U.S. life-science logistics specialist CryoPDP, strengthening its temperature-controlled capabilities across biopharma, advanced therapies and clinical-trial distribution. The move builds on the company’s US$5.7 billion healthcare revenues in 2024, underscoring its ambition to lead global cold-chain logistics through integrated, end-to-end platforms.

On 5 November 2025, Cencora unveiled a landmark US$1 billion investment programme aimed at transforming its U.S. pharmaceutical distribution network through 2030. The initiative includes construction of a new 530,000 sq. ft national distribution centre in Harrison, Ohio, alongside major expansions in California and Alabama. These next-generation hubs will integrate advanced warehouse automation, robotic picking systems and significantly enhanced refrigerated and frozen storage capacity to support the rising flow of specialty pharmaceuticals.

For the pharma wholesale and distribution ecosystem, these developments mark a critical inflection point. The fastest-expanding therapeutic categories—oncology drugs, biologics, vaccines, and GLP-1 therapies—demand ultra-reliable cold-chain control and precision handling. Cencora’s investment signals a recalibration of competitive advantage: wholesalers must now operate as cold-chain, automation and data-driven fulfilment specialists, not merely intermediaries in the supply chain.

The implications are clear for all players across your segmentation—from branded and generic pharmaceutical distributors to vaccine, biologics, and medical-device channels. Strategic alignment with high-performance temperature-controlled logistics partners—or the development of internal capabilities of comparable scale—is rapidly becoming a prerequisite to securing national contracts, institutional tenders and long-term manufacturer partnerships.

As cold chain transitions into a mission-critical asset, market leaders will be defined by their ability to deliver temperature-integrity, operational resilience and technology-enabled distribution excellence across increasingly complex product portfolios.

What would be the Impact of US Trade Tariffs on the Global Pharma Wholesale and Distribution Market?

U.S. trade tariffs can significantly disrupt global pharmaceutical wholesale and distribution by increasing import costs for APIs, finished drugs, packaging materials and medical devices sourced from China, India and Europe. Higher landed costs compress distributor margins and may trigger price adjustments across branded, generic and OTC channels. Tariffs also slow cross-border flow times, forcing wholesalers to hold larger safety stocks and invest more in working capital. For multi-party distributors and PCD/institutional suppliers, tariff volatility increases procurement risk and complicates contracting with manufacturers. Ultimately, tariffs create cost instability, supply uncertainty and operational pressure across the entire distribution ecosystem.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the Pharma Wholesale and Distribution market evolving?
  • What is driving and restraining the Pharma Wholesale and Distribution market?
  • How will each Pharma Wholesale and Distribution submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
  • How will the market shares for each Pharma Wholesale and Distribution submarket develop from 2025 to 2035?
  • What will be the main driver for the overall market from 2025 to 2035?
  • Will leading Pharma Wholesale and Distribution markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the Pharma Wholesale and Distribution projects for these leading companies?
  • How will the industry evolve during the period between 2025 and 2035? What are the implications of
  • Pharma Wholesale and Distribution projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the Pharma Wholesale and Distribution market?
  • Where is the Pharma Wholesale and Distribution market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Pharma Wholesale and Distribution market today, and over the next 10 years:

  • Visiongain’s 303-page report provides 112 tables and 158 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them – NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2035 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

Type

  • Wholesalers
    – Producer Wholesaler
    – Merchant Wholesaler
    – Agents and Brokers
  • Distributor
    – Single Party Distributor
    – Multi Party Distributor

Distribution Type

  • Ethical/Branded Pharma Products Distributors
  • Generic Pharma Products Distributors
  • Propaganda Cum Distribution (PCD) Franchise
  • OTC/Institutional Supply Pharma Distributors
  • Others

Product Type

  • Branded Pharmaceuticals
  • Generic Pharmaceuticals
  • Over-the-counter (OTC) Pharmaceuticals
  • Vaccines
  • Medical Devices
  • Others

End-users

  • Hospitals & Clinics
  • Retail Pharmacies
  • Online / E-Pharmacies
  • Others)

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 24 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • South-East Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

Pharma Wholesale and Distribution Market Report 2025-2035
Need industry data? Please contact us today.

The report also includes profiles for some of the leading companies in the Pharma Wholesale and Distribution Market, 2025 to 2035, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth

  • AmerisourceBergen Corporation
  • Cardinal Health, Inc.
  • CuraScript, Inc.
  • Dakota Drug, Inc.
  • Fortissa
  • Geo-Young Co., Ltd.
  • Kingworld Medicines Group Limited
  • Mckesson Corporation
  • Medipal Holdings Corporation
  • Mutual Drug
  • Petrone Group
  • Prodigy Health LLC
  • Sinopharm Group Co. Ltd.
  • Smith Drug Co., Inc.
  • Walgreens Boots Alliance, Inc.

Overall world revenue for Pharma Wholesale and Distribution Market, 2025 to 2035 in terms of value the market will surpass US$ 1,033.0 billion in 2025, our work calculates. We predict strong revenue growth through to 2035. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Pharma Wholesale and Distribution Market, 2025 to 2035 report help you?

In summary, our 300+ page report provides you with the following knowledge:

  • Revenue forecasts to 2035 for Pharma Wholesale and Distribution Market 2025 to 2035, with forecasts for type, distribution type, product type, and end-users, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2035 for five regional and 24 key national markets – See forecasts for the Pharma Wholesale and Distribution Market, 2025 to 2035 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market – including company profiles for 15 of the major companies involved in the Pharma Wholesale and Distribution Market, 2025 to 2035.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Pharma Wholesale and Distribution Market 2025 to 2035, market-leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Pharma Wholesale and Distribution Market Report 2025-2035 (Including Impact of U.S. Trade Tariffs): Forecasts by Type ((Wholesalers (Producer Wholesaler, Merchant Wholesaler, Agents and Brokers), Distributor (Single Party Distributor, and Multi Party Distributor)), by Distribution Type ((Ethical/Branded Pharma Products Distributors, Generic Pharma Products Distributors, Propaganda Cum Distribution (PCD) Franchise, OTC/Institutional Supply Pharma Distributors, Others)), by Product Type (Branded Pharmaceuticals, Generic Pharmaceuticals, Over-the-counter (OTC) Pharmaceuticals, Vaccines, Medical Devices, Others), by End-users (Hospitals & Clinics, Retail Pharmacies, Online/E-Pharmacies, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Pharma Wholesale and Distribution Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Rising Demand for Prescription and OTC Drugs
3.2.1.2 Healthcare Infrastructure Expansion
3.2.1.3 Regulatory Compliance and Safety Requirements
3.2.1.4 Shift Towards Specialty Drugs and Biologics
3.2.1.5 Growing Global Pharmaceutical Sales
3.2.1.6 Rising Seaborne Pharmaceutical Transportation
3.2.1.7 Automation and Digitalization Driving Industry Growth
3.2.1.8 Implementation of Track and Trace Solutions
3.2.2 Market Restraining Factors
3.2.2.1 Stringent Regulations Imposed by Government
3.2.2.2 Price Pressures Likely to Challenge Market Growth
3.2.2.3 Rise in Pharmaceutical Counterfeiting
3.2.3 Market Opportunities
3.2.3.1 Specializing in Niche Drugs and Therapies
3.2.3.2 Embracing E-commerce and Digital Technologies
3.2.3.3 Focusing on Sustainability and Ethical Sourcing
3.2.3.4 Implementation of AI in Pharmaceutical Supply Chain
3.3 U.S. Tariffs: What’s the Impact on Global Pharma Wholesale and Distribution Market?
3.3.1 Overview
3.3.2 V-Shaped Recovery Scenario
3.3.3 Why V-Shaped Recovery?
3.3.3.1 Impact from Tariffs
3.3.3.2 Market Dynamics and Demand Recovery
3.3.3.3 Policy and Funding Support
3.3.3.4 Timeframe for Recovery
3.3.4 U-Shaped Recovery Scenario
3.3.4.1 Why U-Shaped Recovery?
3.3.4.2 Impact from Tariffs
3.3.4.3 Market Dynamics and Demand Recovery
3.3.4.4 Policy and Funding Support
3.3.4.5 Timeframe for Recovery
3.3.5 L Shaped Recovery Scenario
3.3.5.1 Why L-Shaped Recovery?
3.3.5.2 Impact from Tariffs
3.3.5.3 Market Dynamics and Demand Recovery
3.3.5.4 Policy and Funding Support
3.3.5.5 Timeframe for Recovery
3.3.6 What Strategic Considerations Should Clients Factor into Their Near-term (2025–2030) and Long-term (2025–2035) Planning?
3.3.7 Impact of U.S. and China Trade War on Pharma Wholesale and Distribution Market
3.3.8 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat of Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis

4 Pharma Wholesale and Distribution Market Analysis by Type
4.1 Key Findings
4.2 Type Segment: Market Attractiveness Index
4.3 Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
4.4 Wholesalers
4.4.1 Market Size by Region, 2025-2035 (US$ Billion)
4.4.2 Market Share by Region, 2025 & 2035 (%)
4.4.3 Market Size by Type, 2025-2035 (US$ Billion)
4.4.4 Producer Wholesaler
4.4.5 Merchant Wholesaler
4.4.6 Agents and Brokers
4.5 Distributor
4.5.1 Market Size by Region, 2025-2035 (US$ Billion)
4.5.2 Market Share by Region, 2025 & 2035 (%)
4.5.3 Market Size by Type, 2025-2035 (US$ Billion)
4.5.4 Single Party Distributor
4.5.5 Multi Party Distributor

5 Pharma Wholesale and Distribution Market Analysis by Distribution Type
5.1 Key Findings
5.2 Distribution Type Segment: Market Attractiveness Index
5.3 Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
5.4 Ethical/Branded Pharma Products Distributors
5.4.1 Market Size by Region, 2025-2035 (US$ Billion)
5.4.2 Market Share by Region, 2025 & 2035 (%)
5.5 Generic Pharma Products Distributors
5.5.1 Market Size by Region, 2025-2035 (US$ Billion)
5.5.2 Market Share by Region, 2025 & 2035 (%)
5.6 Propaganda Cum Distribution (PCD) Franchise
5.6.1 Market Size by Region, 2025-2035 (US$ Billion)
5.6.2 Market Share by Region, 2025 & 2035 (%)
5.7 OTC/Institutional Supply Pharma Distributors
5.7.1 Market Size by Region, 2025-2035 (US$ Billion)
5.7.2 Market Share by Region, 2025 & 2035 (%)
5.8 Others
5.8.1 Market Size by Region, 2025-2035 (US$ Billion)
5.8.2 Market Share by Region, 2025 & 2035 (%)

6 Pharma Wholesale and Distribution Market Analysis by Product Type
6.1 Key Findings
6.2 Product Type Segment: Market Attractiveness Index
6.3 Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
6.4 Branded Pharmaceuticals
6.4.1 Market Size by Region, 2025-2035 (US$ Billion)
6.4.2 Market Share by Region, 2025 & 2035 (%)
6.5 Generic Pharmaceuticals
6.5.1 Market Size by Region, 2025-2035 (US$ Billion)
6.5.2 Market Share by Region, 2025 & 2035 (%)
6.6 Over-the-counter (OTC) Pharmaceuticals
6.6.1 Market Size by Region, 2025-2035 (US$ Billion)
6.6.2 Market Share by Region, 2025 & 2035 (%)
6.7 Medical Devices
6.7.1 Market Size by Region, 2025-2035 (US$ Billion)
6.7.2 Market Share by Region, 2025 & 2035 (%)
6.8 Vaccines
6.8.1 Market Size by Region, 2025-2035 (US$ Billion)
6.8.2 Market Share by Region, 2025 & 2035 (%)
6.9 Others
6.9.1 Market Size by Region, 2025-2035 (US$ Billion)
6.9.2 Market Share by Region, 2025 & 2035 (%)

7 Pharma Wholesale and Distribution Market Analysis by End-users
7.1 Key Findings
7.2 End-users Segment: Market Attractiveness Index
7.3 Pharma Wholesale and Distribution Market Size Estimation and Forecast by End-users
7.4 Hospitals and Clinics
7.4.1 Market Size by Region, 2025-2035 (US$ Billion)
7.4.2 Market Share by Region, 2025 & 2035 (%)
7.5 Retail Pharmacies
7.5.1 Market Size by Region, 2025-2035 (US$ Billion)
7.5.2 Market Share by Region, 2025 & 2035 (%)
7.6 Online / E-Pharmacies
7.6.1 Market Size by Region, 2025-2035 (US$ Billion)
7.6.2 Market Share by Region, 2025 & 2035 (%)
7.7 Others
7.7.1 Market Size by Region, 2025-2035 (US$ Billion)
7.7.2 Market Share by Region, 2025 & 2035 (%)

8 Pharma Wholesale and Distribution Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast

9 North America Pharma Wholesale and Distribution Market Analysis
9.1 Key Findings
9.2 North America Pharma Wholesale and Distribution Market Attractiveness Index
9.3 North America Pharma Wholesale and Distribution Market by Country, 2025, 2030 & 2035 (US$ Billion)
9.4 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
9.5 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
9.6 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
9.7 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
9.8 North America Pharma Wholesale and Distribution Market Size Estimation and Forecast by End-users
9.9 U.S. Pharma Wholesale and Distribution Market Analysis
9.10 Canada Pharma Wholesale and Distribution Market Analysis

10 Europe Pharma Wholesale and Distribution Market Analysis
10.1 Key Findings
10.2 Europe Pharma Wholesale and Distribution Market Attractiveness Index
10.3 Europe Pharma Wholesale and Distribution Market by Country, 2025, 2030 & 2035 (US$ Billion)
10.4 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
10.5 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
10.6 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
10.7 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
10.8 Europe Pharma Wholesale and Distribution Market Size Estimation and Forecast by End-users
10.9 Germany Pharma Wholesale and Distribution Market Analysis
10.10 France Pharma Wholesale and Distribution Market Analysis
10.11 UK Pharma Wholesale and Distribution Market Analysis
10.12 Italy Pharma Wholesale and Distribution Market Analysis
10.13 Spain Pharma Wholesale and Distribution Market Analysis
10.14 Russia Pharma Wholesale and Distribution Market Analysis
10.15 Rest of Europe Pharma Wholesale and Distribution Market Analysis

11 Asia Pacific Pharma Wholesale and Distribution Market analysis
11.1 Key Findings
11.2 Asia Pacific Pharma Wholesale and Distribution Market Attractiveness Index
11.3 Asia Pacific Pharma Wholesale and Distribution Market by Country, 2025, 2030 & 2035 (US$ Billion)
11.4 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
11.5 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
11.6 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
11.7 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
11.8 Asia Pacific Pharma Wholesale and Distribution Market Size Estimation and Forecast by End-users
11.9 Japan Pharma Wholesale and Distribution Market Analysis
11.10 China Pharma Wholesale and Distribution Market Analysis
11.11 India Pharma Wholesale and Distribution Market Analysis
11.12 Australia Pharma Wholesale and Distribution Market Analysis
11.13 South Korea Pharma Wholesale and Distribution Market Analysis
11.14 South-East Asia Pharma Wholesale and Distribution Market Analysis
11.15 Rest of Asia Pacific Pharma Wholesale and Distribution Market Analysis

12 Latin America Pharma Wholesale and Distribution Market Analysis
12.1 Key Findings
12.2 Latin America Pharma Wholesale and Distribution Market Attractiveness Index
12.3 Latin America Pharma Wholesale and Distribution Market by Country, 2025, 2030 & 2035 (US$ Billion)
12.4 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
12.5 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
12.6 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
12.7 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
12.8 Latin America Pharma Wholesale and Distribution Market Size Estimation and Forecast by End-users
12.9 Brazil Pharma Wholesale and Distribution Market Analysis
12.10 Mexico Pharma Wholesale and Distribution Market Analysis
12.11 Argentina Pharma Wholesale and Distribution Market Analysis
12.12 Colombia Pharma Wholesale and Distribution Market Analysis
12.13 Rest of Latin America Pharma Wholesale and Distribution Market Analysis

13 MEA Pharma Wholesale and Distribution Market Analysis
13.1 Key Findings
13.2 MEA Pharma Wholesale and Distribution Market Attractiveness Index
13.3 MEA Pharma Wholesale and Distribution Market by Country, 2025, 2030 & 2035 (US$ Billion)
13.4 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Country
13.5 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Product Type
13.6 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Distribution Type
13.7 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by Type
13.8 MEA Pharma Wholesale and Distribution Market Size Estimation and Forecast by End-users
13.9 GCC Pharma Wholesale and Distribution Market Analysis
13.10 South Africa Pharma Wholesale and Distribution Market Analysis
13.11 Rest of MEA Pharma Wholesale and Distribution Market Analysis

14 Company Profiles
14.1 Cencora, Inc.
14.1.1 Company Snapshot
14.1.2 Company Overview
14.1.3 Financial Analysis
14.1.3.1 Net Revenue, 2020-2024
14.1.3.2 Regional Market Shares, 2024
14.1.4 Service Benchmarking
14.1.5 Strategic Outlook
14.2 Cardinal Health, Inc.
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.3.1 Net Revenue, 2020-2024
14.2.3.2 Regional Market Shares, 2024
14.2.4 Service Benchmarking
14.2.5 Strategic Outlook
14.3 CuraScript, Inc.
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Service Benchmarking
14.4 Dakota Drug, Inc.
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Service Benchmarking
14.5 Fortissa
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Service Benchmarking
14.6 Geo-Young Co., Ltd.
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Service Benchmarking
14.7 Kingworld Medicines Group Limited
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Service Benchmarking
14.8 Mckesson Corporation
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2020-2024
14.8.3.2 Regional Market Shares, 2024
14.8.4 Service Benchmarking
14.8.5 Strategic Outlook
14.9 Medipal Holdings Corporation
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2017-2022
14.9.4 Service Benchmarking
14.10 Mutual Drug
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Service Benchmarking
14.11 Petrone Group
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Service Benchmarking
14.11.4 Strategic Outlook
14.12 Prodigy Health LLC
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Service Benchmarking
14.13 Sinopharm Group Co. Ltd.
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.3.1 Net Revenue, 2017-2022
14.13.4 Service Benchmarking
14.14 Smith Drug Co., Inc.
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Service Benchmarking
14.15 Walgreens Boots Alliance, Inc.
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Net Revenue, 2017-2022
14.15.4 Service Benchmarking
14.15.5 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players

List of Tables
Table 1 Pharma Wholesale and Distribution Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
Table 2 Pharma Wholesale and Distribution Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): “V” Shaped Recovery
Table 3 Pharma Wholesale and Distribution Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): “U” Shaped Recovery
Table 4 Pharma Wholesale and Distribution Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): “L” Shaped Recovery
Table 5 Pharma Wholesale and Distribution Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 6 Wholesalers Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 7 Wholesaler Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 8 Distributors Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 9 Distributor Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 10 Pharma Wholesale and Distribution Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 11 Ethical/Branded Pharma Product Distributors Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 12 Generic Pharma Product Distributors Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 13 Propaganda Cum Distribution (PCD) Franchise Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 14 OTC/Institutional Supply Pharma Distributors Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 15 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 16 Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 17 Branded Pharmaceuticals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 18 Generic Pharmaceuticals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 19 Over-the-counter (OTC) Pharmaceuticals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 20 Medical Devices Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 21 Vaccines Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 22 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 23 Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 24 Hospitals & Clinics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 25 Retail Pharmacies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 26 Online / E-Pharmacies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 27 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 28 Pharma Wholesale and Distribution Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 29 North America Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 30 North America Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 31 North America Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 32 North America Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 33 North America Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 34 U.S. Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 35 Canada Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 36 Europe Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 37 Europe Pharma Wholesale and Distribution Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 38 Europe Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 39 Europe Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 40 Europe Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 41 Germany Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 42 France Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 43 UK Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 44 Italy Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 45 Spain Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 46 Russia Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 47 Rest of Europe Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 48 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 49 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 50 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 51 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 52 Asia Pacific Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 53 Japan Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 54 China Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 55 India Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 56 Australia Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 57 South Korea Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 58 South-East Asia Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 59 Rest of Asia Pacific Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 60 Latin America Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 61 Latin America Pharma Wholesale and Distribution Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 62 Latin America Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 63 Latin America Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 64 Latin America Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 65 Brazil Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 66 Mexico Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 67 Argentina Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 68 Colombia Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 69 Rest of Latin America Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 70 MEA Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 71 MEA Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 72 MEA Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 73 MEA Pharma Wholesale and Distribution Market Forecast by Manufacturing Type, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 74 MEA Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 75 GCC Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 76 South Africa Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 77 Rest of MEA Pharma Wholesale and Distribution Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 78 Cencora, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 Cencora, Inc.: Service Benchmarking
Table 80 Cencora, Inc.: Strategic Outlook
Table 81 Cardinal Health, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 Cardinal Health, Inc.: Service Benchmarking
Table 83 Cardinal Health, Inc.: Strategic Outlook
Table 84 CuraScript, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 CuraScript, Inc.: Service Benchmarking
Table 86 Dakota Drug, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 Dakota Drug, Inc.: Service Benchmarking
Table 88 Fortissa: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Fortissa: Service Benchmarking
Table 90 Geo-Young Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Geo-Young Co., Ltd.: Service Benchmarking
Table 92 Kingworld Medicines Group Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Kingworld Medicines Group Limited: Service Benchmarking
Table 94 Mckesson Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Mckesson Corporation: Service Benchmarking
Table 96 Mckesson Corporation: Strategic Outlook
Table 97 Medipal Holdings Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Medipal Holdings Corporation: Service Benchmarking
Table 99 Mutual Drug: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 Mutual Drug: Service Benchmarking
Table 101 Petrone Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Petrone Group: Service Benchmarking
Table 103 Petrone Group: Strategic Outlook
Table 104 Prodigy Health LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Prodigy Health LLC: Service Benchmarking
Table 106 Sinopharm Group Co. Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Sinopharm Group Co. Ltd.: Service Benchmarking
Table 108 Smith Drug Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 109 Smith Drug Co., Inc.: Service Benchmarking
Table 110 Walgreens Boots Alliance, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Walgreens Boots Alliance, Inc.: Service Benchmarking
Table 112 Walgreens Boots Alliance, Inc.: Strategic Outlook

List of Figures
Figure 1 Pharma Wholesale and Distribution Market Segmentation
Figure 2 Pharma Wholesale and Distribution Market by Type: Market Attractiveness Index
Figure 3 Pharma Wholesale and Distribution Market by Distribution Type: Market Attractiveness Index
Figure 4 Pharma Wholesale and Distribution Market by Product Type: Market Attractiveness Index
Figure 5 Pharma Wholesale and Distribution Market Attractiveness Index by Region
Figure 6 Pharma Wholesale and Distribution Market: Market Dynamics
Figure 7 Pharma Wholesale and Distribution Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: V-Shaped Recovery Scenario
Figure 8 Pharma Wholesale and Distribution Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
Figure 9 Pharma Wholesale and Distribution Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
Figure 10 Short Term & Long-Term Planning
Figure 11 Impact of U.S. and China Trade War
Figure 12 Most Impacted Countries
Figure 13 Pharma Wholesale and Distribution Market: Porter’s Five Forces Analysis
Figure 14 Pharma Wholesale and Distribution Market: PEST Analysis
Figure 15 Pharma Wholesale and Distribution Market by Type: Market Attractiveness Index
Figure 16 Pharma Wholesale and Distribution Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 17 Pharma Wholesale and Distribution Market Share Forecast by Type, 2025, 2030, 2035 (%)
Figure 18 Wholesalers Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 19 Wholesalers Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 20 Wholesalers Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 21 Distributor Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 22 Distributor Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 23 Distributors Segment Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 24 Pharma Wholesale and Distribution Market by Distribution Type: Market Attractiveness Index
Figure 25 Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR %)
Figure 26 Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2025, 2030, 2035 (%)
Figure 27 Ethical/Branded Pharma Products Distributors Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 28 Ethical/Branded Pharma Products Distributors Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 29 Generic Pharma Products Distributors Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 30 Generic Pharma Products Distributors Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 31 Propaganda Cum Distribution (PCD) Franchise Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 32 Propaganda Cum Distribution (PCD) Franchise Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 33 OTC/Institutional Supply Pharma Distributors Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 34 OTC/Institutional Supply Pharma Distributors Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 35 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 36 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 37 Pharma Wholesale and Distribution Market by Product Type: Market Attractiveness Index
Figure 38 Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
Figure 39 Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2025, 2030, 2035 (%)
Figure 40 Branded Pharmaceuticals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 41 Branded Pharmaceuticals Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 42 Generic Pharmaceuticals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 43 Generic Pharmaceuticals Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 44 Over-the-counter (OTC) Pharmaceuticals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 45 Over-the-counter (OTC) Pharmaceuticals Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 46 Medical Devices Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 47 Medical Devices Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 48 Vaccines Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 49 Vaccines Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 50 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 51 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 52 Pharma Wholesale and Distribution Market by End-users: Market Attractiveness Index
Figure 53 Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 54 Pharma Wholesale and Distribution Market Share Forecast by End-users, 2025, 2030, 2035 (%)
Figure 55 Hospitals and Clinics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 56 Hospitals and Clinics Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 57 Retail Pharmacies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 58 Retail Pharmacies Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 59 Online / E-Pharmacies Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 60 Online / E-Pharmacies Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 61 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 62 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 63 Pharma Wholesale and Distribution Market Forecast by Region 2025 and 2035, (Revenue, CAGR%)
Figure 64 Pharma Wholesale and Distribution Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 65 Pharma Wholesale and Distribution Market by Region, 2025-2035 (US$ Billion, AGR %)
Figure 66 North America Pharma Wholesale and Distribution Market Attractiveness Index
Figure 67 North America Pharma Wholesale and Distribution Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 68 North America Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 69 North America Pharma Wholesale and Distribution Market Share Forecast by Country, 2025 & 2035 (%)
Figure 70 North America Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
Figure 71 North America Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2025 & 2035 (%)
Figure 72 North America Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR %)
Figure 73 North America Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2025 & 2035 (%)
Figure 74 North America Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
Figure 75 North America Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2025 & 2035 (%)
Figure 76 North America Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 77 North America Pharma Wholesale and Distribution Market Share Forecast by End-users 2025 & 2035 (%)
Figure 78 U.S. Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 79 Canada Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 80 Europe Pharma Wholesale and Distribution Market Attractiveness Index
Figure 81 Europe Pharma Wholesale and Distribution Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 82 Europe Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 83 Europe Pharma Wholesale and Distribution Market Share Forecast by Country, 2025 & 2035 (%)
Figure 84 Europe Pharma Wholesale and Distribution Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 85 Europe Pharma Wholesale and Distribution Market Share Forecast by Type, 2024 & 2034 (%)
Figure 86 Europe Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR %)
Figure 87 Europe Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2025 & 2035 (%)
Figure 88 Europe Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR.%)
Figure 89 Europe Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2025 & 2035 (%)
Figure 90 Europe Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 91 Europe Pharma Wholesale and Distribution Market Share Forecast by End-users 2025 & 2035 (%)
Figure 92 Germany Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 93 France Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 94 UK Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 95 Italy Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 96 Spain Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 97 Russia Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 98 Rest of Europe Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 99 Asia Pacific Pharma Wholesale and Distribution Market Attractiveness Index
Figure 100 Asia Pacific Pharma Wholesale and Distribution Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 101 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 102 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by Country, 2025 & 2035 (%)
Figure 103 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 104 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by Type, 2024 & 2035 (%)
Figure 105 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Distribution Type, .2025-2035 (US$ Billion, AGR %)
Figure 106 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by Distribution .Type, 2025 & 2035 (%)
Figure 107 Asia Pacific Pharma Wholesale and Distribution Market Forecast by Product Type, .2025-2035 (US$ Billion, AGR %)
Figure 108 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by Product .Type, 2025 & 2035 (%)
Figure 109 Asia Pacific Pharma Wholesale and Distribution Market Forecast by End-users, .2025-2035 (US$ Billion, AGR %)
Figure 110 Asia Pacific Pharma Wholesale and Distribution Market Share Forecast by End-users 2025 & 2035 (%)
Figure 111 Japan Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 112 China Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 113 India Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 114 Australia Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 115 South Korea Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 116 South-East Asia Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 117 Rest of Asia Pacific Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 118 Latin America Pharma Wholesale and Distribution Market Attractiveness Index
Figure 119 Latin America Pharma Wholesale and Distribution Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 120 Latin America Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 121 Latin America Pharma Wholesale and Distribution Market Share Forecast by Country, 2025 & 2035 (%)
Figure 122 Latin America Pharma Wholesale and Distribution Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 123 Latin America Pharma Wholesale and Distribution Market Share Forecast by Type, 2025 & 2035 (%)
Figure 124 Latin America Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR %)
Figure 125 Latin America Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2025 & 2035 (%)
Figure 126 Latin America Pharma Wholesale and Distribution Market Forecast by Product Type, (US$ Billion, AGR %)
Figure 127 Latin America Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2025 & 2035 (%)
Figure 128 Latin America Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 129 Latin America Pharma Wholesale and Distribution Market Share Forecast by End-users 2025 & 2035 (%)
Figure 130 Brazil Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 131 Mexico Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 132 Argentina Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 133 Colombia Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 134 Rest of Latin America Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 135 MEA Pharma Wholesale and Distribution Market Attractiveness Index
Figure 136 MEA Pharma Wholesale and Distribution Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 137 MEA Pharma Wholesale and Distribution Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 138 MEA Pharma Wholesale and Distribution Market Share Forecast by Country, 2025 & 2035 (%)
Figure 139 MEA Pharma Wholesale and Distribution Market Forecast by Product Type, 2025-2035 (US$ Billion, AGR %)
Figure 140 MEA Pharma Wholesale and Distribution Market Share Forecast by Product Type, 2025 & 2035 (%)
Figure 141 MEA Pharma Wholesale and Distribution Market Forecast by Distribution Type, 2025-2035 (US$ Billion, AGR %)
Figure 142 MEA Pharma Wholesale and Distribution Market Share Forecast by Distribution Type, 2025 & 2035 (%)
Figure 143 MEA Pharma Wholesale and Distribution Market Forecast by Type, 2025-2035 (US$ Billion, AGR %)
Figure 144 MEA Pharma Wholesale and Distribution Market Share Forecast by Type, 2025 & 2035 (%)
Figure 145 MEA Pharma Wholesale and Distribution Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 146 MEA Pharma Wholesale and Distribution Market Share Forecast by End-users 2025 & 2035 (%)
Figure 147 GCC Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 148 South Africa Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 149 Rest of MEA Pharma Wholesale and Distribution Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 150 Cencora, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 151 Cencora, Inc.: Regional Market Shares, 2024
Figure 152 Cardinal Health, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 153 Cardinal Health, Inc.: Regional Market Shares, 2024
Figure 154 Mckesson Corporation: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 155 Mckesson Corporation: Regional Market Shares, 2024
Figure 156 Medipal Holdings Corporation: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 157 Sinopharm Group Co. Ltd.: Net Revenue, 2017-2022 (US$ Million, AGR %)
Figure 158 Walgreens Boots Alliance, Inc.: Net Revenue, 2017-2022 (US$ Million, AGR %)

List of Companies Profiled in the Report
AmerisourceBergen Corporation
Cardinal Health, Inc.
CuraScript, Inc.
Dakota Drug, Inc.
Fortissa
Geo-Young Co., Ltd.
Kingworld Medicines Group Limited
Mckesson Corporation
Medipal Holdings Corporation
Mutual Drug
Petrone Group
Prodigy Health LLC
Sinopharm Group Co. Ltd.
Smith Drug Co., Inc.
Walgreens Boots Alliance, Inc.

List of Other Companies Mentioned in the Report
AAH Pharmaceuticals
Abbott India
Al-Dawaa Pharmacies
Alfresa Corporation
Alibaba Health
Alliance Healthcare
AstraZeneca
China Resources Pharmaceutical Group
Cipla
DHL Supply Chain
Giuliani Pharma
Korea United Pharm Inc.
Phoenix Group
Protek Group
Sanofi
Shanghai Pharmaceutical Group
Sumitomo Dainippon Pharma
Zuellig Pharma

List of Associations Mentioned in the Report
Association of Pharmaceutical Manufacturers and Wholesalers (AMHW)
Central Drugs Standard Control Organization (CDSCO)
European Medicines Agency
Healthcare Distribution Alliance (HDA)
Italian Medicines Agency
Medicines and Healthcare products Regulatory Agency (MHRA)
National Medical Products Administration (NMPA)
National Pharmaceutical Pricing Observatory
National Reimbursement Drug List (NRDL)
Pharmaceuticals and Medical Devices Agency (PMDA)
Spanish Agency of Medicines and Medical Devices